
Aboriginal women's service tackling financial abuse
The Mudgin-gal centre in Sydney's Redfern has operated for more than three decades, providing a safe space with programs and facilities for women, mothers and families experiencing domestic violence or homelessness.
Sometimes the centre simply serves as a place to drop in for a yarn, and its chief executive Ashlee Donohue says provides a sanctuary for women no matter who they are or what they have experienced.
Mudgin-gal's important work is expanding with a grant of up to $200,000 and mentoring from the Commonwealth Bank to tackle financial abuse in the community.
The support will allow for culturally safe programs like their trauma-informed sacred circle initiative, which focuses on healing while building financial literacy so women can gain an understanding and independence around money.
"This is a big deal for us," Ms Donohue told AAP.
"The fact that there's mentoring with it, we're not just guessing, we're getting proper information from the bank, and that's remarkable."
The grant is part of the bank's Next Chapter Innovation program, which invests in First Nations-led initiatives to provide culturally informed, practical responses to financial abuse.
Other program grant recipients include the Queensland-based Mookai Rosie-Bi-Bayan, which provides healthcare and accommodation to women and children in Cape York, the Northern Peninsula Area and Torres Strait.
The Next Chapter Innovation program was established to help "break the cycle" of financial abuse, Commonwealth Bank's Indigenous business products executive manager Mitchell Heritage said.
"We are proud to back community-led organisations that are delivering real change on the ground," he said.
Financial abuse can look different in Indigenous communities with family pressure and exploitation of cultural obligations sometimes used to control finances, Ms Donohue said.
Many women who are in a financially abusive situation may not be able to recognise it as such she said, which is why it is important to build financial literacy.
"There's a need for our women to understand finances better," Ms Donohue said.
"In reality we've always been behind the eight ball with money in this country - our ancestors worked for no wages - so this skilling up and sharing knowledge in this space hasn't really been done before and that in itself is innovation."
13YARN 13 92 76
Lifeline 13 11 14
1800 RESPECT (1800 737 732)
Men's Referral Service 1300 766 491
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

The Australian
an hour ago
- The Australian
$30m Saturday Megadraw: Winning numbers, luckiest suburbs revealed
Australia's luckiest suburbs for winning the lottery have been revealed ahead of the $30m Saturday Megadraw. More than 533 winners won a collective $1.69bn in the 24-25 financial year, with the most player wins (152) and most prize money ($532.3m) being shared between Victoria and NSW respectively, according to The Lott. Victorians are statistically the most successful Lotto winners from the previous financial year. Picture: NewsWire / Nikki Short Victoria also recorded the highest number of 'millionaires created' with 81, followed by Queensland with 81 and NSW with 76. The biggest individual prize won last year was $100m, which happened three times. Up to a third of Aussie adults are expected to participate in this weekend's draw. The Lott spokesman Matt Hart said winning the lottery was an 'indescribable thrill'. 'While lotteries are games of chance where wins can land any time, we did see some pockets across the country welcome more prizes than others,' he said. These were the luckiest postcodes in each state, according to The Lott data: Queensland: 4870 for Cairns/Earnville - four division one winning entries sold NSW: 2000 in Sydney - four division one winning entries sold Victoria: 3064 for Craigieburn, 3205 for South Melbourne, 3000 for Melbourne, 3105 for Bulleen, 3250 for Colac - two division one winning entries each Tasmania: 7270 for Beaconsfield, 7248 for Mowbray - two winning entries sold South Australia: 5168 for Noarlunga Centre, 5108 for Salisbury/Salisbury Downs, 5000 for Adelaide - two division one winning entries sold Northern Territory: 0812 for Karama sold the biggest winning ticket in the Territory Western Australia: 6062 for Morley - four winning entries sold MELBOURNE, AUSTRALIA - NewsWire Photos - 26 JULY, 2025: A general view of a Lotto sign outside a tobacco shop in Melbourne CBD. Picture: NewsWire / Diego Fedele Mr Hartt said Saturday Megadraws had a reputation for 'creating more millionaires in a single draw than any other game'. 'The big question is whether last financial year's lottery hotspots will continue to live up their reputation this weekend,' he said. 'Some players tell us they deliberately pick lottery outlets that have recently sold a major lottery prize in the hope of continuing the winning streak, while other players choose different outlets believing lightning won't strike twice.' 'As many lottery winners tell us, you've got to be in it for the chance to win it.' Entries into Saturday's $30m megadraw closes at 7.30pm on Saturday night. Jack Nivison Cadet Journalist Jack began his journalism career as a freelancer for the New England Times, a small community paper based in Armidale, regional New South Wales. He is currently a Sydney-based Cadet Journalist at News Corp. Jack Nivison

The Age
2 hours ago
- The Age
Ansett Australia is back for travellers. But not as you knew it
Acquiring the Ansett brand was relatively straightforward, Frantzeskos said. The trademark had lapsed, and the domain name was also available for purchase. He's confident that despite the painful downfall, there are many Australians – particularly those aged 35 and above – with fond memories of the airline. 'It's a shame it went away, but I think that brand voice is still compelling, and people have nostalgia for it,' Frantzeskos said. 'Just because the corporate entity behind something didn't work doesn't mean that the brand still doesn't mean something. When I mention what I'm doing to people, they get a big smile on their face.' The Ansett brand also lives on as a pilot training offering, under the brand Ansett Aviation Training. Frantzeskos, a digital marketing veteran, has worked with Emirates, Saudi Tourism and Dubai Tourism as clients and said that experience will help deliver compelling customer experiences with Ansett. He has partnered with Melbourne-based travel start-up Travlr, which is providing the platform's technical back-end and customer support infrastructure. While many of the AI features are yet to be built out, the entrepreneur said he eventually wants to provide travel experiences for customers that would be possible only with AI. For now, customers can book at near-wholesale prices on flights and accommodation and pay a $99 yearly fee for VIP membership. 'One thing I'm hoping to do is, if you've booked a holiday for your family, we'll know who you are and your name and where you're going, so I want to give you an AI-written jingle and send it to you so it can be the soundtrack of your holiday,' he said. 'I'm a big believer that you don't need armies of people out there doing stuff that can be done better with AI. And the cost of implementation is really declining so much – you don't need thousands of staff and to train them any more. With AI, you can just get going straight away. 'I think there are new, cool, fun experiences we can do what would never be achievable by humans.' Loading He added that, eventually, he believed people wouldn't have to search or plan holidays at all. 'Your travel concierge will know when the kids are on school holidays, or when you need a break, and quietly offer the perfect trip. It's not about replacing people – it's about anticipating and tailoring times when we want to have fun or disconnect.'

The Age
4 hours ago
- The Age
Strategic CEO hire to drive NeuroScientific stem cell therapy release
NeuroScientific Biopharmaceuticals has made a second heavy-hitting appointment in less than a week, bringing in experienced Melbourne-based executive Nathan Smith as its chief executive officer, as the company gears up for the commercial release of its innovative StemSmart stem cell technology. Smith has extensive experience in cell and gene therapies in senior commercial, operational and strategic roles in Australia and the United States, which should prove invaluable as the company navigates the regulatory and commercial pathways for its innovative StemSmart technology. The company says his deep expertise in good practice manufacturing will be critical for converting the biotechnology startup into a scaled-up commercial stem cell company. NeuroScientific acquired the StemSmart technology in late June via its $4.1 million acquisition of unlisted Perth-based stem cell company Isopgen. StemSmart uses a specific type of stem cell, mesenchymal stromal stem cells (MSC), as a last-line infusion treatment for critically ill patients, including those experiencing severe immune complications from bone marrow transplants, kidney and lung transplant rejection and inflammatory Crohn's disease. 'I was attracted to NSB given the historical success of StemSmart in multiple serious clinical disorders and the clear potential of the technology for further development.' NeuroScientific Biopharmaceuticals chief executive officer Nathan Smith Adding to the company's ranks of highly credentialled personnel, NeuroScientific announced on Friday that it had also recruited well-regarded Perth-based paediatric haematologist and oncologist Dr Catherine Cole as its chief medical officer. The news of both appointments has continued to fuel a stellar rise in the company's share price, which traded 11.3 per cent higher today to 24.5 cents on the best turnover since April. The company's share price is up 360 per cent since the start of June. Smith was the director of business development at Melbourne's Cell Therapies, which develops and manufactures advanced cell-based therapies and is located within the city's pioneering Peter MacCallum Cancer Centre. He has held key roles at Genzyme Corporation, Mesoblast Inc and GlaxoSmithKline in the US, as well as other leading companies in the cell therapy sector.